INTERNATIONAL PATENT: TSCAN THERAPEUTICS, INC. FILES APPLICATION FOR "USE OF ANTI-HA-1 AND ANTI-HA-2 BINDING PROTEINS FOR TREATMENT OF AML, ALL AND MDS"

GENEVA, Oct. 20 -- TSCAN THERAPEUTICS, INC. (830 Winter StreetWaltham, MA 02451) filed a patent application (PCT/US2025/023415) for "USE OF ANTI-HA-1 AND ANTI-HA-2 BINDING PROTEINS FOR TREATMENT OF AML, ALL, AND MDS" on Apr 07, 2025. With publication no. WO/2025/217035, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHATTOPADHYAY, Shrikanta (c/o Tscan Therapeutics, Inc.830 Winter StreetWaltham, MA 02451), MACBEATH, Gavin (c/o Tscan Therapeutics, Inc.830 Winter StreetWaltham, MA 02451)

Abstract: The present disclosure en...